Versatope Therapeutics Incorporated

About Versatope Therapeutics Incorporated

Versatope Therapeutics is a clinical-stage company focused on developing immuno-therapeutics using a customized biotechnology platform. Their mission involves using designer extracellular nano-vesicles to provide cross-strain immunity for infectious diseases like Influenza and malaria, as well as targeted therapeutics for cancer.

Products & Services

Biotechnology Platform:A versatile platform based on molecular engineering of proprietary cell lines that produce Recombinant Extracellular Transport Vesicles (RET-Vs) for vaccine and therapeutic delivery.

Vaccine Design:Uses probiotic vesicles to design multi-strain vaccines, offering a competitive advantage over single-strain vaccines with capabilities to display multiple viral variants, protect against emerging strains, confer long-term immunity, and enable rapid synthesis and distribution.

Therapeutics for Cancer:Delivers therapeutic RNA directly into cancer cells using extracellular nano-vesicles.

Specialties

Immuno-Therapeutics Vaccine Technology Recombinant Extracellular Transport Vesicles (RET-Vs) Bioinformatics Synthetic Biology Thermostable Vaccine Design Immunotherapy for Infectious Diseases and Cancer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant (Phase 2 Small Business Innovation Research - SBIR) T: - FT: Grant (Phase 2 Small Business Innovation Research - SBIR)	A: 3000000 MR: - FA: up to $3 million FAN: 3000000	D: 2024-07-29 FD: 2024-07-29	2 investors

Grant (Phase 2 Small Business Innovation Research - SBIR) Latest

2024-07-29

$3.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Drew Weissman

Roberts Family Professor of Vaccine Research

K

Katalin Karikó

F

Frederick G. Hayden

Professor Emeritus, Medicine- Infectious Diseases and International Health

R

Robert B. Belshe

Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology

R

Ralph A. Tripp

Georgia Research Alliance Chair of Animal Health Vaccine Development, GRA Eminent Scholar, Professor

D

David J. Topham

Professor of Microbiology and Immunology and Director of Translational Immunology and Infectious Diseases Institute

View 17 more team members with Pro

Unlock Full Team Directory

Recent News